ID   HMDH_HUMAN              Reviewed;         888 AA.
AC   P04035; B7Z3Y9; Q8N190;
DT   01-NOV-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1986, sequence version 1.
DT   10-MAY-2017, entry version 204.
DE   RecName: Full=3-hydroxy-3-methylglutaryl-coenzyme A reductase;
DE            Short=HMG-CoA reductase;
DE            EC=1.1.1.34;
GN   Name=HMGCR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2991281;
RA   Luskey K.L., Stevens B.;
RT   "Human 3-hydroxy-3-methylglutaryl coenzyme A reductase. Conserved
RT   domains responsible for catalytic activity and sterol-regulated
RT   degradation.";
RL   J. Biol. Chem. 260:10271-10277(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Nakajima T., Iwaki K., Hamakubo T., Kodama T., Emi M.;
RT   "Human HMG-CoA reductase gene.";
RL   Submitted (JUN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Rieder M.J., da Ponte S.H., Kuldanek S.A., Rajkumar N., Smith J.D.,
RA   Toth E.J., Nickerson D.A.;
RL   Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   ENZYME REGULATION.
RX   PubMed=6995544;
RA   Brown M.S., Goldstein J.L.;
RT   "Multivalent feedback regulation of HMG CoA reductase, a control
RT   mechanism coordinating isoprenoid synthesis and cell growth.";
RL   J. Lipid Res. 21:505-517(1980).
RN   [8]
RP   INTERACTION WITH INSIG1, AND UBIQUITINATION.
RX   PubMed=12535518; DOI=10.1016/S1097-2765(02)00822-5;
RA   Sever N., Yang T., Brown M.S., Goldstein J.L., DeBose-Boyd R.A.;
RT   "Accelerated degradation of HMG CoA reductase mediated by binding of
RT   insig-1 to its sterol-sensing domain.";
RL   Mol. Cell 11:25-33(2003).
RN   [9]
RP   INTERACTION WITH INSIG1, UBIQUITINATION AT LYS-89 AND LYS-248,
RP   GLYCOSYLATION, AND MUTAGENESIS OF 75-TYR--TYR-77; LYS-89 AND LYS-248.
RX   PubMed=19458199; DOI=10.1091/mbc.E08-09-0953;
RA   Leichner G.S., Avner R., Harats D., Roitelman J.;
RT   "Dislocation of HMG-CoA reductase and Insig-1, two polytopic
RT   endoplasmic reticulum proteins, en route to proteasomal degradation.";
RL   Mol. Biol. Cell 20:3330-3341(2009).
RN   [10]
RP   UBIQUITINATION.
RX   PubMed=21778231; DOI=10.1074/jbc.M111.278036;
RA   Leichner G.S., Avner R., Harats D., Roitelman J.;
RT   "Metabolically regulated endoplasmic reticulum-associated degradation
RT   of 3-hydroxy-3-methylglutaryl-CoA reductase: evidence for requirement
RT   of a geranylgeranylated protein.";
RL   J. Biol. Chem. 286:32150-32161(2011).
RN   [11]
RP   TISSUE SPECIFICITY (ISOFORM 3), AND ALTERNATIVE SPLICING.
RX   PubMed=22989091; DOI=10.1186/1471-2199-13-29;
RA   Stormo C., Kringen M.K., Grimholt R.M., Berg J.P., Piehler A.P.;
RT   "A novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR)
RT   splice variant with an alternative exon 1 potentially encoding an
RT   extended N-terminus.";
RL   BMC Mol. Biol. 13:29-29(2012).
RN   [12]
RP   INTERACTION WITH UBIAD1.
RX   PubMed=23169578; DOI=10.1002/humu.22230;
RA   Nickerson M.L., Bosley A.D., Weiss J.S., Kostiha B.N., Hirota Y.,
RA   Brandt W., Esposito D., Kinoshita S., Wessjohann L., Morham S.G.,
RA   Andresson T., Kruth H.S., Okano T., Dean M.;
RT   "The UBIAD1 prenyltransferase links menaquione-4 synthesis to
RT   cholesterol metabolic enzymes.";
RL   Hum. Mutat. 34:317-329(2013).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-504, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-872, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 422-888, AND SUBUNIT.
RX   PubMed=10698924; DOI=10.1093/emboj/19.5.819;
RA   Istvan E.S., Palnitkar M., Buchanan S.K., Deisenhofer J.;
RT   "Crystal structure of the catalytic portion of human HMG-CoA
RT   reductase: insights into regulation of activity and catalysis.";
RL   EMBO J. 19:819-830(2000).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 426-888.
RX   PubMed=11349148; DOI=10.1126/science.1059344;
RA   Istvan E.S., Deisenhofer J.;
RT   "Structural mechanism for statin inhibition of HMG-CoA reductase.";
RL   Science 292:1160-1164(2001).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.39 ANGSTROMS) OF 441-875 IN COMPLEX WITH
RP   STATIN-BASED INHIBITORS.
RX   PubMed=18540668; DOI=10.1021/jm7015057;
RA   Sarver R.W., Bills E., Bolton G., Bratton L.D., Caspers N.L.,
RA   Dunbar J.B., Harris M.S., Hutchings R.H., Kennedy R.M., Larsen S.D.,
RA   Pavlovsky A., Pfefferkorn J.A., Bainbridge G.;
RT   "Thermodynamic and structure guided design of statin based inhibitors
RT   of 3-hydroxy-3-methylglutaryl coenzyme A reductase.";
RL   J. Med. Chem. 51:3804-3813(2008).
RN   [18]
RP   VARIANT VAL-638.
RX   PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [19]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
CC   -!- FUNCTION: Transmembrane glycoprotein that is the rate-limiting
CC       enzyme in cholesterol biosynthesis as well as in the biosynthesis
CC       of nonsterol isoprenoids that are essential for normal cell
CC       function including ubiquinone and geranylgeranyl proteins.
CC   -!- CATALYTIC ACTIVITY: (R)-mevalonate + CoA + 2 NADP(+) = (S)-3-
CC       hydroxy-3-methylglutaryl-CoA + 2 NADPH. {ECO:0000255|PROSITE-
CC       ProRule:PRU10003}.
CC   -!- ENZYME REGULATION: Regulated by a negative feedback mechanism
CC       through sterols and non-sterol metabolites derived from
CC       mevalonate. Inhibited by statins, a class of hypolipidemic agents
CC       used as pharmaceuticals to lower cholesterol levels in individuals
CC       at risk from cardiovascular disease due to hypercholesterolemia.
CC       Inhibition of HMGCR in the liver stimulates the LDL-receptors,
CC       which results in an increased clearance of LDL from the
CC       bloodstream and a decrease in blood cholesterol levels. The first
CC       results can be seen after one week of statin use and the effect is
CC       maximal after four to six weeks. {ECO:0000269|PubMed:6995544}.
CC   -!- PATHWAY: Metabolic intermediate biosynthesis; (R)-mevalonate
CC       biosynthesis; (R)-mevalonate from acetyl-CoA: step 3/3.
CC   -!- SUBUNIT: Homodimer. Interacts (via its SSD) with INSIG1; the
CC       interaction, accelerated by sterols, leads to the recruitment of
CC       HMGCR to AMFR/gp78 for its ubiquitination by the sterol-mediated
CC       ERAD pathway. Interacts with UBIAD1. {ECO:0000269|PubMed:10698924,
CC       ECO:0000269|PubMed:12535518, ECO:0000269|PubMed:18540668,
CC       ECO:0000269|PubMed:19458199, ECO:0000269|PubMed:23169578}.
CC   -!- INTERACTION:
CC       Q9Y5Z9:UBIAD1; NbExp=3; IntAct=EBI-465513, EBI-2819725;
CC       Q9Y5Z9-1:UBIAD1; NbExp=5; IntAct=EBI-465513, EBI-6621921;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P04035-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P04035-2; Sequence=VSP_002207;
CC         Note=No experimental confirmation available.;
CC       Name=3; Synonyms=HMGCR-1b;
CC         IsoId=P04035-3; Sequence=VSP_046492;
CC         Note=Most highly expressed transcript in skin, esophagus, and
CC         uterine cervix.;
CC   -!- PTM: N-glycosylated. Deglycosylated by NGLY1 on release from the
CC       endoplasmic reticulum (ER) in a sterol-mediated manner.
CC       {ECO:0000269|PubMed:19458199}.
CC   -!- PTM: Undergoes sterol-mediated ubiquitination and ER-association
CC       degradation (ERAD). Accumulation of sterols in the endoplasmic
CC       reticulum (ER) membrane, triggers binding of the reductase to the
CC       ER membrane protein INSIG1. This INSIG1 binding leads to the
CC       recruitment of the ubiquitin ligase, AMFR/gp78, initiating
CC       ubiquitination of the reductase. The ubiquitinated reductase is
CC       then extracted from the ER membrane and delivered to cytosolic 26S
CC       proteosomes by a mechanism probably mediated by the ATPase
CC       Valosin-containing protein VCP/p97. Lys-248 is the main site of
CC       ubiquitination. Ubiquitination is enhanced by the presence of a
CC       geranylgeranylated protein. {ECO:0000269|PubMed:12535518,
CC       ECO:0000269|PubMed:19458199, ECO:0000269|PubMed:21778231}.
CC   -!- SIMILARITY: Belongs to the HMG-CoA reductase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAH12375.1; Type=Frameshift; Positions=122; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M11058; AAA52679.1; -; mRNA.
DR   EMBL; AF273765; AAG21343.1; -; Genomic_DNA.
DR   EMBL; AF273754; AAG21343.1; JOINED; Genomic_DNA.
DR   EMBL; AF273755; AAG21343.1; JOINED; Genomic_DNA.
DR   EMBL; AF273756; AAG21343.1; JOINED; Genomic_DNA.
DR   EMBL; AF273757; AAG21343.1; JOINED; Genomic_DNA.
DR   EMBL; AF273758; AAG21343.1; JOINED; Genomic_DNA.
DR   EMBL; AF273759; AAG21343.1; JOINED; Genomic_DNA.
DR   EMBL; AF273760; AAG21343.1; JOINED; Genomic_DNA.
DR   EMBL; AF273761; AAG21343.1; JOINED; Genomic_DNA.
DR   EMBL; AF273762; AAG21343.1; JOINED; Genomic_DNA.
DR   EMBL; AF273763; AAG21343.1; JOINED; Genomic_DNA.
DR   EMBL; AF273764; AAG21343.1; JOINED; Genomic_DNA.
DR   EMBL; AY321356; AAP72015.1; -; Genomic_DNA.
DR   EMBL; AK296499; BAH12375.1; ALT_FRAME; mRNA.
DR   EMBL; AC008897; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC033692; AAH33692.1; -; mRNA.
DR   CCDS; CCDS4027.1; -. [P04035-1]
DR   CCDS; CCDS47234.1; -. [P04035-2]
DR   PIR; A00356; RDHUE.
DR   RefSeq; NP_000850.1; NM_000859.2. [P04035-1]
DR   RefSeq; NP_001124468.1; NM_001130996.1. [P04035-2]
DR   RefSeq; XP_011541659.1; XM_011543357.1. [P04035-3]
DR   RefSeq; XP_011541660.1; XM_011543358.1. [P04035-1]
DR   UniGene; Hs.628096; -.
DR   UniGene; Hs.643495; -.
DR   PDB; 1DQ8; X-ray; 2.10 A; A/B/C/D=426-888.
DR   PDB; 1DQ9; X-ray; 2.80 A; A/B/C/D=426-888.
DR   PDB; 1DQA; X-ray; 2.00 A; A/B/C/D=426-888.
DR   PDB; 1HW8; X-ray; 2.10 A; A/B/C/D=426-888.
DR   PDB; 1HW9; X-ray; 2.33 A; A/B/C/D=426-888.
DR   PDB; 1HWI; X-ray; 2.30 A; A/B/C/D=426-888.
DR   PDB; 1HWJ; X-ray; 2.26 A; A/B/C/D=426-888.
DR   PDB; 1HWK; X-ray; 2.22 A; A/B/C/D=426-888.
DR   PDB; 1HWL; X-ray; 2.10 A; A/B/C/D=426-888.
DR   PDB; 2Q1L; X-ray; 2.05 A; A/B/C/D=441-875.
DR   PDB; 2Q6B; X-ray; 2.00 A; A/B/C/D=441-875.
DR   PDB; 2Q6C; X-ray; 2.00 A; A/B/C/D=441-875.
DR   PDB; 2R4F; X-ray; 1.70 A; A/B/C/D=441-875.
DR   PDB; 3BGL; X-ray; 2.23 A; A/B/C/D=441-875.
DR   PDB; 3CCT; X-ray; 2.12 A; A/B/C/D=441-875.
DR   PDB; 3CCW; X-ray; 2.10 A; A/B/C/D=441-875.
DR   PDB; 3CCZ; X-ray; 1.70 A; A/B/C/D=441-875.
DR   PDB; 3CD0; X-ray; 2.40 A; A/B/C/D=441-875.
DR   PDB; 3CD5; X-ray; 2.39 A; A/B/C/D=441-875.
DR   PDB; 3CD7; X-ray; 2.05 A; A/B/C/D=441-875.
DR   PDB; 3CDA; X-ray; 2.07 A; A/B/C/D=441-875.
DR   PDB; 3CDB; X-ray; 2.30 A; A/B/C/D=441-875.
DR   PDBsum; 1DQ8; -.
DR   PDBsum; 1DQ9; -.
DR   PDBsum; 1DQA; -.
DR   PDBsum; 1HW8; -.
DR   PDBsum; 1HW9; -.
DR   PDBsum; 1HWI; -.
DR   PDBsum; 1HWJ; -.
DR   PDBsum; 1HWK; -.
DR   PDBsum; 1HWL; -.
DR   PDBsum; 2Q1L; -.
DR   PDBsum; 2Q6B; -.
DR   PDBsum; 2Q6C; -.
DR   PDBsum; 2R4F; -.
DR   PDBsum; 3BGL; -.
DR   PDBsum; 3CCT; -.
DR   PDBsum; 3CCW; -.
DR   PDBsum; 3CCZ; -.
DR   PDBsum; 3CD0; -.
DR   PDBsum; 3CD5; -.
DR   PDBsum; 3CD7; -.
DR   PDBsum; 3CDA; -.
DR   PDBsum; 3CDB; -.
DR   ProteinModelPortal; P04035; -.
DR   SMR; P04035; -.
DR   BioGrid; 109399; 33.
DR   IntAct; P04035; 7.
DR   STRING; 9606.ENSP00000287936; -.
DR   BindingDB; P04035; -.
DR   ChEMBL; CHEMBL402; -.
DR   DrugBank; DB03169; (S)-Hmg-Coa.
DR   DrugBank; DB03461; 2'-Monophosphoadenosine 5'-Diphosphoribose.
DR   DrugBank; DB04377; 3-Hydroxy-3-Methyl-Glutaric Acid.
DR   DrugBank; DB01076; Atorvastatin.
DR   DrugBank; DB00439; Cerivastatin.
DR   DrugBank; DB01992; Coenzyme A.
DR   DrugBank; DB01095; Fluvastatin.
DR   DrugBank; DB00227; Lovastatin.
DR   DrugBank; DB06693; Mevastatin.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB08860; Pitavastatin.
DR   DrugBank; DB00175; Pravastatin.
DR   DrugBank; DB01098; Rosuvastatin.
DR   DrugBank; DB00641; Simvastatin.
DR   DrugBank; DB05342; SP-01A.
DR   DrugBank; DB05317; TAK-475.
DR   GuidetoPHARMACOLOGY; 639; -.
DR   SwissLipids; SLP:000001246; -.
DR   TCDB; 2.A.6.6.5; the resistance-nodulation-cell division (rnd) superfamily.
DR   iPTMnet; P04035; -.
DR   PhosphoSitePlus; P04035; -.
DR   BioMuta; HMGCR; -.
DR   DMDM; 123343; -.
DR   EPD; P04035; -.
DR   MaxQB; P04035; -.
DR   PaxDb; P04035; -.
DR   PeptideAtlas; P04035; -.
DR   PRIDE; P04035; -.
DR   DNASU; 3156; -.
DR   Ensembl; ENST00000287936; ENSP00000287936; ENSG00000113161. [P04035-1]
DR   Ensembl; ENST00000343975; ENSP00000340816; ENSG00000113161. [P04035-2]
DR   Ensembl; ENST00000511206; ENSP00000426745; ENSG00000113161. [P04035-1]
DR   GeneID; 3156; -.
DR   KEGG; hsa:3156; -.
DR   UCSC; uc003kdp.4; human. [P04035-1]
DR   CTD; 3156; -.
DR   DisGeNET; 3156; -.
DR   GeneCards; HMGCR; -.
DR   HGNC; HGNC:5006; HMGCR.
DR   HPA; CAB016797; -.
DR   HPA; HPA008338; -.
DR   MIM; 142910; gene+phenotype.
DR   neXtProt; NX_P04035; -.
DR   OpenTargets; ENSG00000113161; -.
DR   PharmGKB; PA189; -.
DR   eggNOG; KOG2480; Eukaryota.
DR   eggNOG; COG1257; LUCA.
DR   GeneTree; ENSGT00840000129910; -.
DR   HOGENOM; HOG000183489; -.
DR   HOVERGEN; HBG000453; -.
DR   InParanoid; P04035; -.
DR   KO; K00021; -.
DR   OMA; PNEECLQ; -.
DR   OrthoDB; EOG091G0I1B; -.
DR   PhylomeDB; P04035; -.
DR   TreeFam; TF105362; -.
DR   BioCyc; MetaCyc:HS03652-MONOMER; -.
DR   BRENDA; 1.1.1.34; 2681.
DR   Reactome; R-HSA-191273; Cholesterol biosynthesis.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-2426168; Activation of gene expression by SREBF (SREBP).
DR   SABIO-RK; P04035; -.
DR   SIGNOR; P04035; -.
DR   UniPathway; UPA00058; UER00103.
DR   ChiTaRS; HMGCR; human.
DR   EvolutionaryTrace; P04035; -.
DR   GeneWiki; HMG-CoA_reductase; -.
DR   GenomeRNAi; 3156; -.
DR   PRO; PR:P04035; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000113161; -.
DR   CleanEx; HS_HMGCR; -.
DR   ExpressionAtlas; P04035; baseline and differential.
DR   Genevisible; P04035; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005778; C:peroxisomal membrane; IDA:UniProtKB.
DR   GO; GO:0050662; F:coenzyme binding; IDA:UniProtKB.
DR   GO; GO:0004420; F:hydroxymethylglutaryl-CoA reductase (NADPH) activity; IBA:GO_Central.
DR   GO; GO:0042282; F:hydroxymethylglutaryl-CoA reductase activity; IDA:UniProtKB.
DR   GO; GO:0070402; F:NADPH binding; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0051721; F:protein phosphatase 2A binding; IEA:Ensembl.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; IDA:CACAO.
DR   GO; GO:0015936; P:coenzyme A metabolic process; IEA:InterPro.
DR   GO; GO:0008299; P:isoprenoid biosynthetic process; IBA:GO_Central.
DR   GO; GO:0045445; P:myoblast differentiation; IEA:Ensembl.
DR   GO; GO:0097756; P:negative regulation of blood vessel diameter; IEA:Ensembl.
DR   GO; GO:0061179; P:negative regulation of insulin secretion involved in cellular response to glucose stimulus; IEA:Ensembl.
DR   GO; GO:0043407; P:negative regulation of MAP kinase activity; IEA:Ensembl.
DR   GO; GO:0010664; P:negative regulation of striated muscle cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0061045; P:negative regulation of wound healing; IEA:Ensembl.
DR   GO; GO:0010666; P:positive regulation of cardiac muscle cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IEA:Ensembl.
DR   GO; GO:0048643; P:positive regulation of skeletal muscle tissue development; IEA:Ensembl.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:0032874; P:positive regulation of stress-activated MAPK cascade; IEA:Ensembl.
DR   GO; GO:0051262; P:protein tetramerization; IDA:UniProtKB.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0007584; P:response to nutrient; IEA:Ensembl.
DR   GO; GO:0006743; P:ubiquinone metabolic process; IEA:Ensembl.
DR   GO; GO:0008542; P:visual learning; IEA:Ensembl.
DR   CDD; cd00643; HMG-CoA_reductase_classI; 1.
DR   Gene3D; 1.10.3270.10; -; 1.
DR   Gene3D; 3.30.70.420; -; 1.
DR   Gene3D; 3.90.770.10; -; 1.
DR   InterPro; IPR002202; HMG_CoA_Rdtase.
DR   InterPro; IPR023074; HMG_CoA_Rdtase_cat.
DR   InterPro; IPR023076; HMG_CoA_Rdtase_CS.
DR   InterPro; IPR004554; HMG_CoA_Rdtase_eu_arc.
DR   InterPro; IPR004816; HMG_CoA_Rdtase_metazoan.
DR   InterPro; IPR023282; HMG_CoA_Rdtase_N.
DR   InterPro; IPR009023; HMG_CoA_Rdtase_NAD(P)-bd_dom.
DR   InterPro; IPR009029; HMG_CoA_Rdtase_sub-bd_dom.
DR   InterPro; IPR000731; SSD.
DR   PANTHER; PTHR10572; PTHR10572; 1.
DR   Pfam; PF00368; HMG-CoA_red; 1.
DR   Pfam; PF12349; Sterol-sensing; 1.
DR   PRINTS; PR00071; HMGCOARDTASE.
DR   SUPFAM; SSF55035; SSF55035; 1.
DR   SUPFAM; SSF56542; SSF56542; 2.
DR   TIGRFAMs; TIGR00920; 2A060605; 1.
DR   TIGRFAMs; TIGR00533; HMG_CoA_R_NADP; 1.
DR   PROSITE; PS00066; HMG_COA_REDUCTASE_1; 1.
DR   PROSITE; PS00318; HMG_COA_REDUCTASE_2; 1.
DR   PROSITE; PS01192; HMG_COA_REDUCTASE_3; 1.
DR   PROSITE; PS50065; HMG_COA_REDUCTASE_4; 1.
DR   PROSITE; PS50156; SSD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cholesterol biosynthesis;
KW   Cholesterol metabolism; Complete proteome; Endoplasmic reticulum;
KW   Glycoprotein; Isopeptide bond; Lipid biosynthesis; Lipid metabolism;
KW   Membrane; NADP; Oxidoreductase; Phosphoprotein; Polymorphism;
KW   Reference proteome; Steroid biosynthesis; Steroid metabolism;
KW   Sterol biosynthesis; Sterol metabolism; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   CHAIN         1    888       3-hydroxy-3-methylglutaryl-coenzyme A
FT                                reductase.
FT                                /FTId=PRO_0000114419.
FT   TRANSMEM     10     39       Helical. {ECO:0000255}.
FT   TRANSMEM     57     78       Helical. {ECO:0000255}.
FT   TRANSMEM     90    114       Helical. {ECO:0000255}.
FT   TRANSMEM    124    149       Helical. {ECO:0000255}.
FT   TRANSMEM    160    187       Helical. {ECO:0000255}.
FT   TRANSMEM    192    220       Helical. {ECO:0000255}.
FT   TRANSMEM    315    339       Helical. {ECO:0000255}.
FT   DOMAIN       61    218       SSD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00199}.
FT   REGION      340    449       Linker.
FT   REGION      450    888       Catalytic.
FT   MOTIF        75     78       INSIG-binding motif.
FT   COMPBIAS    243    246       Poly-Glu.
FT   ACT_SITE    559    559       Charge relay system.
FT   ACT_SITE    691    691       Charge relay system.
FT   ACT_SITE    767    767       Charge relay system.
FT   ACT_SITE    866    866       Proton donor.
FT   MOD_RES     504    504       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     872    872       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD    281    281       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    296    296       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    419    419       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    518    518       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    870    870       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CROSSLNK     89     89       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:19458199}.
FT   CROSSLNK    248    248       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in ubiquitin).
FT                                {ECO:0000269|PubMed:19458199}.
FT   VAR_SEQ       1      1       M -> MQWMSHTRERDAGSKDSVATM (in isoform
FT                                3). {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046492.
FT   VAR_SEQ     522    574       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_002207.
FT   VARIANT     638    638       I -> V (in dbSNP:rs5908).
FT                                {ECO:0000269|PubMed:10391209}.
FT                                /FTId=VAR_011954.
FT   MUTAGEN      75     77       YIY->AIA: Reduced sterol-mediated release
FT                                from the ER. Not deglycosylated in
FT                                response to sterols.
FT                                {ECO:0000269|PubMed:19458199}.
FT   MUTAGEN      89     89       K->R: Abolishes sterol-mediated
FT                                ubiquitination and degradation; when
FT                                associated with R-248.
FT                                {ECO:0000269|PubMed:19458199}.
FT   MUTAGEN     248    248       K->R: Abolishes sterol-mediated
FT                                ubiquitination and degradation; when
FT                                associated with R-89.
FT                                {ECO:0000269|PubMed:19458199}.
FT   HELIX       445    453       {ECO:0000244|PDB:2R4F}.
FT   TURN        455    457       {ECO:0000244|PDB:2R4F}.
FT   HELIX       458    460       {ECO:0000244|PDB:2R4F}.
FT   HELIX       464    472       {ECO:0000244|PDB:2R4F}.
FT   STRAND      474    476       {ECO:0000244|PDB:3CDA}.
FT   HELIX       478    480       {ECO:0000244|PDB:2R4F}.
FT   HELIX       481    484       {ECO:0000244|PDB:2R4F}.
FT   STRAND      485    487       {ECO:0000244|PDB:2R4F}.
FT   HELIX       488    502       {ECO:0000244|PDB:2R4F}.
FT   STRAND      503    505       {ECO:0000244|PDB:2R4F}.
FT   HELIX       508    511       {ECO:0000244|PDB:2R4F}.
FT   STRAND      515    517       {ECO:0000244|PDB:1DQ9}.
FT   HELIX       519    521       {ECO:0000244|PDB:2R4F}.
FT   TURN        522    525       {ECO:0000244|PDB:2R4F}.
FT   STRAND      528    546       {ECO:0000244|PDB:2R4F}.
FT   STRAND      549    556       {ECO:0000244|PDB:2R4F}.
FT   HELIX       562    575       {ECO:0000244|PDB:2R4F}.
FT   STRAND      579    590       {ECO:0000244|PDB:2R4F}.
FT   STRAND      593    595       {ECO:0000244|PDB:2R4F}.
FT   HELIX       599    610       {ECO:0000244|PDB:2R4F}.
FT   HELIX       612    623       {ECO:0000244|PDB:2R4F}.
FT   STRAND      635    639       {ECO:0000244|PDB:2R4F}.
FT   STRAND      642    650       {ECO:0000244|PDB:2R4F}.
FT   HELIX       657    674       {ECO:0000244|PDB:2R4F}.
FT   STRAND      679    683       {ECO:0000244|PDB:2R4F}.
FT   STRAND      686    688       {ECO:0000244|PDB:1DQA}.
FT   HELIX       695    700       {ECO:0000244|PDB:2R4F}.
FT   STRAND      703    712       {ECO:0000244|PDB:2R4F}.
FT   HELIX       714    719       {ECO:0000244|PDB:2R4F}.
FT   STRAND      721    723       {ECO:0000244|PDB:2R4F}.
FT   HELIX       725    736       {ECO:0000244|PDB:2R4F}.
FT   HELIX       738    742       {ECO:0000244|PDB:2R4F}.
FT   STRAND      746    752       {ECO:0000244|PDB:2R4F}.
FT   HELIX       753    763       {ECO:0000244|PDB:2R4F}.
FT   HELIX       768    770       {ECO:0000244|PDB:2R4F}.
FT   HELIX       771    774       {ECO:0000244|PDB:2R4F}.
FT   STRAND      777    785       {ECO:0000244|PDB:2R4F}.
FT   STRAND      790    800       {ECO:0000244|PDB:2R4F}.
FT   STRAND      804    806       {ECO:0000244|PDB:2R4F}.
FT   HELIX       807    810       {ECO:0000244|PDB:2R4F}.
FT   HELIX       812    820       {ECO:0000244|PDB:2R4F}.
FT   STRAND      828    830       {ECO:0000244|PDB:2R4F}.
FT   HELIX       833    859       {ECO:0000244|PDB:2R4F}.
FT   HELIX       862    869       {ECO:0000244|PDB:1DQA}.
SQ   SEQUENCE   888 AA;  97476 MW;  49B610DCCCFA26B6 CRC64;
     MLSRLFRMHG LFVASHPWEV IVGTVTLTIC MMSMNMFTGN NKICGWNYEC PKFEEDVLSS
     DIIILTITRC IAILYIYFQF QNLRQLGSKY ILGIAGLFTI FSSFVFSTVV IHFLDKELTG
     LNEALPFFLL LIDLSRASTL AKFALSSNSQ DEVRENIARG MAILGPTFTL DALVECLVIG
     VGTMSGVRQL EIMCCFGCMS VLANYFVFMT FFPACVSLVL ELSRESREGR PIWQLSHFAR
     VLEEEENKPN PVTQRVKMIM SLGLVLVHAH SRWIADPSPQ NSTADTSKVS LGLDENVSKR
     IEPSVSLWQF YLSKMISMDI EQVITLSLAL LLAVKYIFFE QTETESTLSL KNPITSPVVT
     QKKVPDNCCR REPMLVRNNQ KCDSVEEETG INRERKVEVI KPLVAETDTP NRATFVVGNS
     SLLDTSSVLV TQEPEIELPR EPRPNEECLQ ILGNAEKGAK FLSDAEIIQL VNAKHIPAYK
     LETLMETHER GVSIRRQLLS KKLSEPSSLQ YLPYRDYNYS LVMGACCENV IGYMPIPVGV
     AGPLCLDEKE FQVPMATTEG CLVASTNRGC RAIGLGGGAS SRVLADGMTR GPVVRLPRAC
     DSAEVKAWLE TSEGFAVIKE AFDSTSRFAR LQKLHTSIAG RNLYIRFQSR SGDAMGMNMI
     SKGTEKALSK LHEYFPEMQI LAVSGNYCTD KKPAAINWIE GRGKSVVCEA VIPAKVVREV
     LKTTTEAMIE VNINKNLVGS AMAGSIGGYN AHAANIVTAI YIACGQDAAQ NVGSSNCITL
     MEASGPTNED LYISCTMPSI EIGTVGGGTN LLPQQACLQM LGVQGACKDN PGENARQLAR
     IVCGTVMAGE LSLMAALAAG HLVKSHMIHN RSKINLQDLQ GACTKKTA
//
